Real-World Effectiveness of Cladribine Tablets in Individuals with Multiple Sclerosis: Data from a Multi-Center Italian Study

被引：0

作者：

Lucchini, Matteo ^{[1
]}

Borriello, Giovanna ^{[2
,3
]}

Haggiag, Shalom ^{[4
]}

Nicoletti, Carolina ^{[5
]}

Fantozzi, Roberta ^{[6
]}

Buscarinu, Maria Chiara ^{[7
]}

Ferrazzano, Gina ^{[8
]}

Cortese, Antonio ^{[9
]}

Marinelli, Fabiana ^{[10
]}

Monteleone, Fabrizia ^{[11
]}

Centonze, Diego ^{[5
]}

Conte, Antonella ^{[8
]}

Ferraro, Elisabetta ^{[9
]}

Gasperini, Claudio ^{[4
]}

Marfia, Girolama Alessandra ^{[5
]}

Pozzilli, Carlo ^{[12
]}

Salvetti, Marco ^{[7
]}

Barbuti, Elena ^{[12
]}

Bianco, Assunta ^{[1
]}

Carlomagno, Vincenzo ^{[1
]}

Cruciani, Alessandro ^{[13
]}

De Giglio, Laura ^{[9
]}

Dionisi, Claudia ^{[5
]}

Ianniello, Antonio ^{[2
,8
]}

Malimpensa, Leonardo ^{[6
]}

Nasello, Martina ^{[7
]}

Nociti, Viviana ^{[1
]}

Prosperini, Luca ^{[4
]}

Tortorella, Carla ^{[4
]}

Mirabella, Massimiliano ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, IRCCS, Fdn Policlin Univ Agostino Gemelli, Rome, Italy

[2] San Pietro Fatebenefratelli Hosp, Rome, Italy

[3] Univ Naples Federico II, Naples, Italy

[4] Azienda Osped San Camillo Forlanini, Rome, Italy

[5] Tor Vergata Univ, Rome, Italy

[6] IRCCS Neuromed, Pozzilli, IS, Italy

[7] St Andrea Hosp, Ctr NESMOS, Rome, Italy

[8] Sapienza Univ Rome, Rome, Italy

[9] San Filippo Neri Hosp, Rome, Italy

[10] Osped Spaziani, Frosinone, Italy

[11] Osped Santa Maria Goretti, Latina, Italy

[12] Univ Rome Sapienza, S Andrea Hosp, Rome, Italy

[13] Univ Campus Biomed, Rome, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P351/1989

引用

页码：376 / 377

页数：2

共 50 条

[21] REAL-WORLD EFFECTIVENESS AND SAFETY OF TOFACITINIB IN CROHN'S DISEASE: A MULTI-CENTER STUDY
Fenster, Marc
Khatiwada, Aava
Wang, Wenfei
Dimopoulos, Christina
Hirten, Robert
Gutierrez, Alexandra
Colombel, Jean Frederic
Cohen, Benjamin
Ciorba, Matthew A.
Rubin, David T.
Ungaro, Ryan C.
Pekow, Joel R.
Deepak, Parakkal
GASTROENTEROLOGY, 2020, 158 (06) : S1211 - S1211
[22] Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study
Barbuti, Elena
Castiello, Alessia
Pozzilli, Valeria
Carotenuto, Antonio
Tomasso, Ilaria
Moccia, Marcello
Ruggieri, Serena
Borriello, Giovanna
Lanzillo, Roberta
Morra, Vincenzo Brescia
Pozzilli, Carlo
Petracca, Maria
NEUROTHERAPEUTICS, 2025, 22 (02)
[23] Long-term effectiveness in patients previously enrolled in the Cladribine Tablets pivotal trials: a real-world evidence analysis using data from the Italian multiple sclerosis registry (CLARINET-MS)
Patti, F.
Visconti, A.
Capacchione, A.
Trojano, M.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 298 - 298
[24] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
Conway, Devon S.
Nicholas, Jacqueline A.
Thompson, Nicolas R.
Mowry, Ellen M.
Naismith, Robert T.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
[25] Real-world use of cladribine tablets (Completion rates and treatment persistence) In patients with multiple sclerosis in England: the CLARENCE Study
Brownlee, W.
Amin, A.
Ashton, L.
Herbert, A.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 666 - 667
[26] Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
Brownlee, Wallace
Amin, Amerah
Ashton, Luke
Herbert, Alex
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
[27] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
Aerts, S.
Khan, H.
Severijns, D.
Popescu, V.
Peeters, L. M.
Van Wijmeersch, B.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
[28] Cladribine use in multiple sclerosis: a monocentric real-world experience
Pilotto, Silvy
Mellino, Paolo
Carmagnini, Daniele
Frau, Jessica
Coghe, Giancarlo
Cocco, Eleonora
Lorefice, Lorena
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
[29] Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal
Santos, Monica
Sequeira, Joao
Abreu, Pedro
Guerreiro, Rui
Santos, Mariana
Ferreira, Joao
Brum, Marisa
Ladeira, Filipa
Leitao, Lia
Dias, Rafael
Sa, Maria Jose
Salgado, Vasco
Capela, Carlos
de Sa, Joao
CLINICAL NEUROPHARMACOLOGY, 2023, 46 (03) : 105 - 111
[30] Real world experience with cladribine tablets in the management of relapsing multiple sclerosis in Qatar
Canibano, Beatriz Garcia
Okar, Lina
Baniamer, Yahya Zakarya
Deleu, Dirk
CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 247

← 1 2 3 4 5 →